Gelesis' Series B Round

Gelesis raised a round of funding on May 12, 2011.

Gelesis is developing a smart pill (Gelesis100) to fulfill the unmet need for a product that can safely cause significant weight loss. Gelesis100 was developed for overweight and obese individuals as …

Articles about Gelesis' Series B Round: